These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 15942642)

  • 41. [Combined cell therapy by using dendritic cells, T-cells and NK cells to human polymorphic cancer].
    Matsushita N; Kobayashi Y; Tanaka Y; Nakao M; Shimizu K; Takeshita N; Tanigawa K; Aruga A
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1655-8. PubMed ID: 15553674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The mechanism of organophosphorus pesticide-induced inhibition of cytolytic activity of killer cells.
    Li Q; Kawada T
    Cell Mol Immunol; 2006 Jun; 3(3):171-8. PubMed ID: 16893497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytotoxic cellular mediators of the immune response to neoplasia: a review.
    Khavari P
    Yale J Biol Med; 1987; 60(5):409-19. PubMed ID: 3321723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bovine natural killer cells.
    Boysen P; Storset AK
    Vet Immunol Immunopathol; 2009 Aug; 130(3-4):163-77. PubMed ID: 19339058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytotoxic lymphocytes.
    Sinkovics JG
    Ann Clin Lab Sci; 1986; 16(6):488-96. PubMed ID: 3492170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
    Bose A; Baral R
    Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Social support, psychological distress, and natural killer cell activity in ovarian cancer.
    Lutgendorf SK; Sood AK; Anderson B; McGinn S; Maiseri H; Dao M; Sorosky JI; De Geest K; Ritchie J; Lubaroff DM
    J Clin Oncol; 2005 Oct; 23(28):7105-13. PubMed ID: 16192594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted cellular therapy with natural killer cells.
    Klingemann H; Boissel L
    Horm Metab Res; 2008 Feb; 40(2):122-5. PubMed ID: 18283630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spermine-directed immunosuppression of cervical carcinoma cell sensitivity to a majority of lymphokine-activated killer lymphocyte cytotoxicity.
    Evans CH; Lee TS; Flugelman AA
    Nat Immun; 1995; 14(3):157-63. PubMed ID: 8832899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Interleukin-2 and cancer treatment].
    Taguchi T
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):1-10. PubMed ID: 3510586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Function of lymphocyte homing-associated adhesion molecules on human natural killer and lymphokine-activated killer cells.
    Uksila J; Salmi M; Butcher EC; Tarkkanen J; Jalkanen S
    J Immunol; 1997 Feb; 158(4):1610-7. PubMed ID: 9029096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Locoregional immunochemotherapy in hepatocellular carcinoma.
    Kountouras J; Boura P; Kouklakis G
    Hepatogastroenterology; 2002; 49(46):1109-12. PubMed ID: 12143214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subpopulation analysis of human granular lymphocytes: associations with age, gender and cytotoxic activity.
    Tilden AB; Grossi CE; Itoh K; Cloud GA; Dougherty PA; Balch CM
    Nat Immun Cell Growth Regul; 1986; 5(2):90-9. PubMed ID: 3724768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ; Kuo ML
    Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
    Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
    Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel approaches using natural killer cells in cancer therapy.
    Suck G
    Semin Cancer Biol; 2006 Oct; 16(5):412-8. PubMed ID: 16914327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S
    Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NK cells: innate immunity against hematological malignancies?
    Costello RT; Fauriat C; Sivori S; Marcenaro E; Olive D
    Trends Immunol; 2004 Jun; 25(6):328-33. PubMed ID: 15145323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Soluble HLA class I molecules in malignant pleural and peritoneal effusions and its possible role on NK and LAK cytotoxicity.
    Amirghofran Z; Sheikhi AK; Kumar PV; Saberi Firouzi M
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):443-8. PubMed ID: 12200601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
    Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
    J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.